Literature DB >> 17089410

Mouse Rab11-FIP4 regulates proliferation and differentiation of retinal progenitors in a Rab11-independent manner.

Akihiko Muto1, Yutaka Aoki, Sumiko Watanabe.   

Abstract

We identified Rab11-family interacting protein 4 (Rab11-FIP4) as a gene strongly expressed in the developing mouse retina. The major transcript encoding a full-length protein, mRab11-FIP4A, was expressed predominantly in neural tissues; whereas an alternative transcript encoding an N-terminally truncated form of the protein, mRab11-FIP4B, was expressed ubiquitously as a minor form. Gain-of-function of mRab11-FIP4A in retina promoted cell cycle exit and increased subpopulations of retinal cells localized in the inner nuclear layer, such as bipolar cells and Müller glia. Reversal of the phenotype was observed in the loss-of-function experiment. Furthermore, Shh signaling was suggested to be involved in these functions. Analysis using truncation mutants revealed the essential role of the N-terminal region containing a conserved EF-hand motif for the retinal phenotypes induced by the expression of mRab11-FIP4A, whereas binding to Rab11 was dispensable, suggesting the involvement of a novel Rab11-independent mechanism for mRab11-FIP4A action in the regulation of retinal development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17089410     DOI: 10.1002/dvdy.21009

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  9 in total

1.  Hypoxia upregulates Rab11-family interacting protein 4 through HIF-1α to promote the metastasis of hepatocellular carcinoma.

Authors:  F Hu; X Deng; X Yang; H Jin; D Gu; X Lv; C Wang; Y Zhang; X Huo; Q Shen; Q Luo; F Zhao; T Ge; F Zhao; W Chu; H Shu; M Yao; J Fan; W Qin
Journal:  Oncogene       Date:  2015-03-09       Impact factor: 9.867

2.  Rab11FIP1-deficient mice develop spontaneous inflammation and show increased susceptibility to colon damage.

Authors:  Sudiksha Rathan-Kumar; Joseph T Roland; Michael Momoh; Anna Goldstein; Lynne A Lapierre; Elizabeth Manning; Louise Mitchell; Jim Norman; Izumi Kaji; James R Goldenring
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-07-12       Impact factor: 4.871

3.  HCMV-encoded glycoprotein M (UL100) interacts with Rab11 effector protein FIP4.

Authors:  Magdalena A Krzyzaniak; Michael Mach; William J Britt
Journal:  Traffic       Date:  2009-10       Impact factor: 6.215

4.  Tumor susceptibility gene 101 (TSG101) is a novel binding-partner for the class II Rab11-FIPs.

Authors:  Conor P Horgan; Sara R Hanscom; Eoin E Kelly; Mary W McCaffrey
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

5.  High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer.

Authors:  Yun He; Mengsi Ye; Lingling Zhou; Yunfeng Shan; Guangrong Lu; Yuhui Zhou; Jinwei Zhong; Jihang Zheng; Zhanxiong Xue; Zhenzhai Cai
Journal:  Int J Oncol       Date:  2016-12-30       Impact factor: 5.650

6.  Dynamic Polarization of Rab11a Modulates Crb2a Localization and Impacts Signaling to Regulate Retinal Neurogenesis.

Authors:  Brian S Clark; Joel B Miesfeld; Michael A Flinn; Ross F Collery; Brian A Link
Journal:  Front Cell Dev Biol       Date:  2021-02-09

7.  Gene expression changes in the motor cortex mediating motor skill learning.

Authors:  Vincent C K Cheung; Caroline Deboer; Elizabeth Hanson; Marta Tunesi; Mara D'Onofrio; Ivan Arisi; Rossella Brandi; Antonino Cattaneo; Ki A Goosens
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

8.  Functional Genomics Identifies Tis21-Dependent Mechanisms and Putative Cancer Drug Targets Underlying Medulloblastoma Shh-Type Development.

Authors:  Giulia Gentile; Manuela Ceccarelli; Laura Micheli; Felice Tirone; Sebastiano Cavallaro
Journal:  Front Pharmacol       Date:  2016-11-30       Impact factor: 5.810

9.  Proteomic analysis of chick retina during early recovery from lens‑induced myopia.

Authors:  Yun Yun Zhou; Rachel Ka Man Chun; Jian Chao Wang; Bing Zuo; King Kit Li; Thomas Chuen Lam; Quan Liu; Chi-Ho To
Journal:  Mol Med Rep       Date:  2018-05-03       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.